Results 271 to 280 of about 412,177 (358)

Superoxide anion release from circulating neutrophils in interstitial pulmonary fibrosis. Study of patients and experimental animal model.

, 1992
Yoko Ishihara, Fusayo Wagai, Haruo Watanabe, Jun Kagawa   +3 more
openalex   +2 more sources

MUC5B Polymorphism and Susceptibility to Idiopathic Pulmonary Fibrosis in Morocco. [PDF]

Cureus
Senhaji L, Abbassi M, Senhaji N, Benmaamar S, Dani L, El Rhazi K, Karhate M, Serraj M, El Biaze M, Benjelloun MC, Ouldim K, Bouguenouch L, Amara B.   +12 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis

, 1999
Minoru Hasegawa, Shinichi Sato, Kazuhiko Takehara   +2 more
openalex   +2 more sources

Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review. [PDF]

Pulm Ther
Montero IE, Hernandez-Gonzalez F, Sellares J.   +2 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. [PDF]

Cell Death Discov
Zheng H, Zhang L, Wang C, Wang Y, Zeng C.   +4 more
europepmc   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Prognostic significance of HALP score in İdiopathic Pulmonary Fibrosis-related mortality. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Çolak M, Çoban H, Sarıoğlu N, Yumrukuz Şenel M, Erel F.   +4 more
europepmc   +1 more source